Inactive Instrument

All News PREDILIFE Euronext Paris

Equities

ALPRE

FR0010169920

End-of-day quote Euronext Paris Other stock markets
-	-

2023	Predilife: a project accredited by Finance Innovation	CF
2023	Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Predilife : IN EXTENSO FINANCE UPDATES COVERAGE ON PREDILIFE STOCK; TARGET PRICE OF EUR 25.07 REPRESENTS +391% POTENTIAL UPSIDE	01/05	AT
Predilife : Valuation of MammoRisk(R) software	25/04	AT
Predilife: a project accredited by Finance Innovation	04/23/04	CF
Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15	CI
Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Predilife: predictive assessment contract with Colas	12/23/12	CF
Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Predilife Taps Eurofins to Conduct Genetic Testing of Saliva Samples	20/21/20	MT
Global markets live: Valneva, Glencore, Facebook, Roche, Hertz...	18/21/18
Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	28/21/28	CI
Global markets live: Valneva,Boeing, Facebook, Kubota, Otis...	23/21/23
Global markets live: Credit Suisse, Apple, Verizon...	03/21/03
PrediLife : and the Institut Curie Announce a Partnership Covering Genetic Analyses for MammoRisk®, the Next-Generation Test Predicting the Risk of Breast Cancer	06/19/06	BU
Predilife S.A. and Institut Curie Announce Partnership Covering Genetic Analyses for Mammorisk, the Next-Generation Test Predicting the Risk of Breast Cancer	06/19/06	CI
Predilife S.A. has completed an IPO in the amount of €3.591232 million.	18/18/18	CI
Predilife S.A. has filed an IPO in the amount of €7.006296 million.	04/18/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW